Drug Stocks Will Only Do Well if We Have Doom and Gloom: Analyst
- CNBC
VICKS V911F SPEED READ THERMOMETER WITH IN-SIGHT *8 SECONDS
VARIOUS: Asian and European stocks tumble but Japan's PM insists his county's economy is robust and analyst counsels against doom and gloom
June 11th 2010 Retail Sales Disappoints (-1.2% Actual vs. +0.4% Consensus)
Stick With These Restaurant Stocks, Analyst
Marc Faber - US Dollars Will Be Worthless - Tech Ticker - 09-22-09
Oil to Rise to $90 By End-2010
Previous Page
Next Page
Drug Stocks Will Only Do Well if We Have Doom and Gloom: Analyst
Jack Scannell, research analyst at Sanford C. Bernstein, told CNBC , "if you are a macro bull you wouldn't want to earn drug stocks, if you are a macro bear you would. The second half of 2011 was a very good time for drug stocks, not because the fundamentals of the pharmaceutical sector were getting
CNBC | February 7, 2012
